Schedule 13D ownership disclosure

Onconova Therapeutics Inc

Security class unavailable · CUSIP: 68232V306

Event date: 2018-04-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,503,169
Percent of class
20.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-18-000327
Form type
SC 13D/A
Filer
683 Capital Management, LLC
CIK
CIK 1404574
Filed
May 01, 2018
Reporting period
Apr 27, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub